US 2023/0143893 A1 · ISOLATION AND PURIFICATION OF EXOSOMES FOR REGENERATIVE MEDICINE

Abstract

The present application provides a method of isolating highly purified and characterized exosomes from tissue and cellular sources for the purpose of regenerative medicine as well as a composition including an exosome or an exosomal compound or component. The composition is used for the therapeutic treatment of various physiological damages and diseases, including skin or cutaneous damages/diseases, cardiovascular diseases, ophthalmic diseases, neurological diseases, viral diseases, and cancer among other damages and diseases.

Claims21

Dependent claims

A method of isolating an exosome or an exosomal product from a tissue source comprising isolating the tissue source;

and purifying the exosome or the exosomal product from the tissue source;
wherein the exosome or the exosomal product comprises a micro RNA, a protein, and/or a cellular marker.

Dependencies are inferred from the claim text.

Facts

Application

17/913,301Filed 23 Mar 2021

Priority

23 Mar 2020

Published

11 May 2023

Term ends

Not estimatedThe source records don’t support an estimate.

Classification8 codes

A61K 35/12
Medicinal preparations containing materials or reaction products thereof with undetermined constitution: materials from mammals; Compositions…
A61K 35/51
Reproductive organs: umbilical cord; Umbilical cord blood; Umbilical stem cells
A61P 31/12
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics: antivirals
A61P 35/00
Antineoplastic agents

Isolation and purification of exosomes for regenerative medicine

Life of this patent

Isolation and purification of exosomes for regenerative medicine

Life of this patent

Abstract

Claims21